复发性复发性多发性硬化症患者高效疾病修饰疗法的治疗结果:一项纵向观察性研究
Raed Alroughani1, Samar Farouk Ahmed2
1Division of Neurology, Department of Medicine, Amiri Hospital, Arabian Gulf Street, Sharq, Kuwait.
Multiple sclerosis and related disorders
|February 15, 2026
概括
早期使用高效疾病修饰疗法 (HE-DMT) 显著改善了复发性复发性多发性硬化症 (RRMS) 患者的治疗结果. 奥克雷利祖马布和纳塔利祖马布显示高效,而治疗决策应考虑个体耐受性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高效的疾病修饰疗法 (HE-DMT) 已经改变了复发性复发性多发性硬化症 (RRMS) 的管理.
- 现实数据证实,HE-DMT改善了RRMS中的残疾和控制疾病活动.
研究的目的:
- 评估在RRMS中HE-DMT (克拉德里宾,纳塔利祖马布,奥克雷祖马布,阿勒姆图祖马布,芬戈利莫德,瑞图西马布) 的实际有效性.
- 在RRMS患者中分析HE-DMT的治疗和中止模式.
主要方法:
- 对1408名RRMS患者进行了回顾性,观察性,纵向性,多中心研究.
- 数据来源于科威特国家MS登记处.
- 评估了无复发状态,残疾进展/改善 (CDP/CDI),EDSS变化,NEDA-3和停药率.
主要成果:
- 第一线的HE-DMT实现了高无复发率 (≥80%) 和NEDA-3 (≥75%);ocrelizumab和natalizumab显示出更高的疗效.
- 随着纳塔利祖马布,奥克雷祖马布和瑞图西马布 (p < 0.001) 观察到的扩大残疾状态量表 (EDSS) 显著减少.
- 停药率各不相同,ocrelizumab显示最低率 (5.4%) 和 alemtuzumab最高 (86.9%).
结论:
- 在RRMS中早期启动HE-DMT显著影响疾病活动和残疾.
- 治疗效果随着晚期的治疗线路而降低,强调早期干预.
- 不同的耐受性需要个性化的HE-DMT选择用于RRMS管理.
相关概念视频
01:26Longitudinal Studies
540
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
540
02:20Longitudinal Research
13.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.5K
01:29Therapeutic Drug Monitoring: Affecting Factors
256
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
256